Cingulate Financial Statements From 2010 to 2025

CING Stock  USD 3.53  0.07  2.02%   
Cingulate's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Cingulate's valuation are provided below:
Gross Profit
-12.1 M
Market Capitalization
23.9 M
Earnings Share
(2.77)
There are over one hundred nineteen available fundamental signals for Cingulate, which can be analyzed over time and compared to other ratios. Active traders should verify all of Cingulate prevailing fundamental drivers against the trend between 2010 and 2025 to make sure the company can sustain itself down the road.
Check Cingulate financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cingulate's main balance sheet or income statement drivers, such as Net Interest Income of 104.2 K, Depreciation And Amortization of 634.3 K or Interest Expense of 94 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.39. Cingulate financial statements analysis is a perfect complement when working with Cingulate Valuation or Volatility modules.
  
Build AI portfolio with Cingulate Stock
Check out the analysis of Cingulate Correlation against competitors.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.

Cingulate Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets11.7 M14.9 M7.7 M
Slightly volatile
Short and Long Term Debt Total3.6 M5.1 M2.6 M
Slightly volatile
Total Current Liabilities5.4 MM3.9 M
Slightly volatile
Net Tangible Assets2.4 M4.5 M1.6 M
Slightly volatile
Property Plant And Equipment Net2.8 M2.2 M3.8 M
Slightly volatile
Current Deferred Revenue858.3 K691.5 K613.1 K
Slightly volatile
Accounts Payable1.9 M1.3 M1.8 M
Very volatile
Cash6.6 M12.2 M2.9 M
Slightly volatile
Non Current Assets Total2.8 M2.2 M3.9 M
Slightly volatile
Cash And Short Term Investments6.6 M12.2 M2.9 M
Slightly volatile
Net Receivables25 K26.3 K142.2 K
Very volatile
Common Stock Shares Outstanding2.2 M3.8 M1.7 M
Slightly volatile
Liabilities And Stockholders Equity11.7 M14.9 M7.7 M
Slightly volatile
Non Current Liabilities Total1.2 M2.4 M1.5 M
Slightly volatile
Capital Lease Obligations128.3 K135.1 K1.7 M
Slightly volatile
Other Current Assets402 K423.2 K620.8 K
Slightly volatile
Other Stockholder Equity69.5 M115.9 M28 M
Slightly volatile
Total Liabilities6.7 M7.4 M5.3 M
Slightly volatile
Property Plant And Equipment Gross5.8 M5.5 M4.9 M
Slightly volatile
Total Current Assets7.8 M12.7 M3.7 M
Slightly volatile
Accumulated Other Comprehensive Income13319081.4056
Slightly volatile
Capital Stock323340465.9 K
Slightly volatile
Short Term Debt2.4 M2.7 M1.2 M
Slightly volatile
Common Stock3233402.4 M
Pretty Stable
Property Plant Equipment3.1 M3.2 M3.9 M
Slightly volatile
Other Liabilities18.9 K21.3 K23.2 K
Slightly volatile
Short and Long Term DebtM2.5 M1.5 M
Slightly volatile
Non Current Liabilities Other18.9 K21.3 K23.2 K
Slightly volatile
Long Term Debt1.9 M2.2 M2.4 M
Slightly volatile

Cingulate Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization634.3 K653.1 K356.5 K
Slightly volatile
Selling General Administrative7.1 M6.2 M4.1 M
Slightly volatile
Selling And Marketing Expenses458.2 K670.5 K372.5 K
Slightly volatile
Other Operating Expenses17.5 M15.6 M13.6 M
Slightly volatile
Research Development10.4 M9.4 M9.3 M
Pretty Stable
Cost Of Revenue676.1 K653.1 K373.4 K
Slightly volatile
Total Operating Expenses16.9 M15 M13.4 M
Slightly volatile
Reconciled Depreciation568.5 K653.1 K330 K
Slightly volatile

Cingulate Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow49.8 K52.4 K2.1 M
Pretty Stable
Depreciation583.6 K653.1 K336.1 K
Slightly volatile
Capital Expenditures376.3 K211.8 K771.3 K
Slightly volatile
Total Cash From Financing Activities15.8 M30.8 M9.8 M
Slightly volatile
End Period Cash Flow6.6 M12.2 M2.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables1.5 M2.9 M1.1 M
Slightly volatile
Capex To Depreciation0.310.32433.7462
Slightly volatile
Payables Turnover1.00.51410.4565
Slightly volatile
Average Inventory51.2 K49.3 K49.7 K
Slightly volatile
Cash Per Share2.653.20341.5796
Slightly volatile
Days Payables Outstanding6747102.8 K
Slightly volatile
Income Quality1.131.186940.7354
Slightly volatile
Current Ratio3.782.54641.7125
Slightly volatile
Capex Per Share0.05280.05560.5226
Slightly volatile
Average Receivables16.4 K18.4 K20.1 K
Slightly volatile
Interest Debt Per Share1.471.36361.6119
Pretty Stable
Debt To Assets0.350.3430.411
Pretty Stable
Days Of Payables Outstanding6747102.8 K
Slightly volatile
Ebt Per Ebit0.810.99370.986
Pretty Stable
Effective Tax Rate0.00.00.0054
Slightly volatile
Long Term Debt To Capitalization0.20.220.2418
Slightly volatile
Quick Ratio3.782.54641.7117
Slightly volatile
Net Income Per E B T0.80.90.9815
Slightly volatile
Cash Ratio3.262.4561.3922
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.161.01151.0874
Slightly volatile
Debt Ratio0.350.3430.411
Pretty Stable

Cingulate Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap15 M16.9 M18.4 M
Slightly volatile
Enterprise Value9.3 M10.5 M11.5 M
Slightly volatile

Cingulate Fundamental Market Drivers

Cash And Short Term Investments12.2 M

Cingulate Upcoming Events

8th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Cingulate Financial Statements

Cingulate stakeholders use historical fundamental indicators, such as Cingulate's revenue or net income, to determine how well the company is positioned to perform in the future. Although Cingulate investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cingulate's assets and liabilities are reflected in the revenues and expenses on Cingulate's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cingulate. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue691.5 K858.3 K
Cost Of Revenue653.1 K676.1 K

Currently Active Assets on Macroaxis

When determining whether Cingulate is a strong investment it is important to analyze Cingulate's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cingulate's future performance. For an informed investment choice regarding Cingulate Stock, refer to the following important reports:
Check out the analysis of Cingulate Correlation against competitors.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cingulate. If investors know Cingulate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cingulate listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.77)
Return On Assets
(1.07)
Return On Equity
(2.76)
The market value of Cingulate is measured differently than its book value, which is the value of Cingulate that is recorded on the company's balance sheet. Investors also form their own opinion of Cingulate's value that differs from its market value or its book value, called intrinsic value, which is Cingulate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cingulate's market value can be influenced by many factors that don't directly affect Cingulate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cingulate's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cingulate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cingulate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.